Skip to search.
 FTSE 100 Down 0.48%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.59 Down 0.09(5.36%) 24 Aug 21:00
|After Hours: : 1.59 Down 0.00 (0.01%) 21:47
Prev Close:1.68
Open:1.68
Bid:1.61 x 4000
Ask:1.71 x 400
1y Target Est:3.75
Beta:1.5242
Earnings Date:8 Nov - 14 Nov (Est.)
Day's Range:1.59 - 1.70
52wk Range:1.30 - 2.99
Volume:1,539,080
Avg Vol (3m):1,463,160
Market Cap:386.78m
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 5.36%386.78m
OREXDown 7.37%58.64m
GSKDown 1.15%106.70b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.35
Quarterly EPS Est (Sep-16) :-0.07
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors to address unmet medical needs in the United States and South Korea. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback